ArticleBiomedicines2021

Fatty Acid Synthase Inhibitor Platensimycin Intervenes the Development of Nonalcoholic Fatty Liver Disease in a Mouse Model.

Meng Su et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.